Screener
Vir Biotechnology, Inc. VIR EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s EBITDA?
- Vir Biotechnology, Inc. (VIR) reported EBITDA of $76.27M in Q2 2026.
- How has Vir Biotechnology, Inc.'s EBITDA changed year-over-year?
- Vir Biotechnology, Inc.'s EBITDA increased by 166.0% year-over-year, from -$115.5M to $76.27M.
- What is the long-term trend for Vir Biotechnology, Inc.'s EBITDA?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s EBITDA has grown at a 3.1% compound annual growth rate (CAGR), from $426.11M to -$467.65M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Vir Biotechnology, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude